Molecular Partners
Lam Tang's work experience includes roles as a Director of Business Evaluation & Product Strategy at Molecular Partners since 2021. Prior to that, they were the Managing Director & Founder of Tanxel GmbH starting in 2019. From 2015 to 2021, they worked as a Pharmaceutical Business Development Consultant. Lam served as a Project Leader at Addex Therapeutics from 2008 to 2012. Before that, they worked as a Senior Scientist and Medicinal Chemist at Xention from 2003 to 2008.
Lam Tang obtained a BA, MA, and PhD degree in Chemistry from the University of Oxford from 1993 to 2000. Afterward, they pursued a Post-Doctoral Fellowship in Chemical Biology at Stanford University from 2001 to 2003. In 2013, Lam Tang attended the University of Warwick - Warwick Business School and obtained a Master of Business Administration (MBA) degree. Additionally, in 2014, they attended the Mannheim Business School for an MBA program specializing in Mergers and Restructuring.
This person is not in any offices
Molecular Partners
3 followers
About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics.